PinUp: The Internet of Things and the Impact on Outcomes and Adherence
Welcome to the April 25, 2017, issue of Pharma Industry News Update (aka PinUp). The drug industry should focus on using Internet of Things technology to improve health outcomes. Better adherence and profits will then follow.
PinUp: The Internet of Things and the Impact on Outcomes and Adherence
Welcome to the April 25, 2017, issue of Pharma Industry News Update (aka PinUp). The drug industry should focus on using Internet of Things technology to improve health outcomes. Better adherence and profits will then follow.
PinUp: Go Boldly & March for Science, Why I March
Welcome to the April 21, 2017, issue of Pharma Industry News Update (aka PinUp). This issue is devoted to the March for Science.
PinUp: The Impact of FDA User Fees & Less Rigorous Scientific Proof on Drug...
Welcome to the April 18, 2017, issue of Pharma Industry News Update (aka PinUp). More user fees paid to the FDA by the drug industry and the push for less rigorous scientific proof in clinical trials may lead to faster drug approvals, but also more deaths due to side effects. Where’s the balance between speed and safety?
PinUp: Patient Centricity Finally Pays Off for Pharma, more…
Welcome to the April 11, 2017, issue of Pharma Industry News Update (aka PinUp). Patient Centricity is finally paying off for drug companies in a BIG way, but it has nothing to do with designing more effective clinical trials or better marketing. It has everything to do with influencing lawmakers and especially the FDA.
PinUp: Dr. Scott Gottlieb Answers Questions About Drug Safety, Speeding FDA’s Drug Approval Process,...
Welcome to the April 7, 2017, issue of Pharma Industry News Update (aka PinUp). Where's the balance between drug safety and speeding up clinical trials to bring drugs to market faster? That was a major issue underscoring the testimony of Dr. Scott Gottlieb, president Trump's nominee to head the FDA, before the U.S. Senate Committee on Health, Education, Labor and Pensions.
PinUp: Making Sense of Direct-to-Consumer Ad Spending: Patients vs. TV vs. Digital, more…
Welcome to the April 4, 2017, issue of Pharma Industry News Update (aka PinUp). Data about how much money the U.S. pharmaceutical industry spends on promoting drugs to consumers come from several sources, which often report different numbers. That makes it difficult to ferret out what portion of the total is spend on TV and digital, the two most interesting channels.
PinUp: Drug Names, Sham Speaker Sessions, Gottlieb’s $Millions, Canada Strikes Back at Pfizer CEO,...
Welcome to the March 31, 2017, issue of Pharma Industry News Update (aka PinUp). This issue begins with an analysis of drug names, many of which are absurd. From there we move on to the absurdity of Canada 'freeloading' off U.S. innovation to the million$ paid to Gottlieb by pharma, to fake physician speaker events.
PinUp: Medical Journal Pharma Advertising Refuses to Die, the Digital Ad Context Problem, more…
Welcome to the March 28, 2017, issue of Pharma Industry News Update (aka PinUp). The latest data from Kantar Media show that the death of medical journal advertising has been greatly exaggerated. This issue presents the spending numbers for the past few years. Pharma digital advertising, however, may not be so successful unless a major problem is solved.
PinUp: Big Pharma Racks Up Facebook Likes But Not So Much from Patients, Got...
Welcome to the March 24, 2017, issue of Pharma Industry News Update (aka PinUp). Let's contemplate how big drug companies can get hundreds of thousands of 'likes' on Facebook but score very low among patient groups worldwide. Only 25% of patients, for example, think pharma marketing is ethical. A case in point is Low-T direct-to-consumer advertising.